DeepVerge (DVRG) said it notes recent market speculation regarding forthcoming loan repayments and a potential equity fundraising.

Author @ZaksTradersCafe

The Company has been in talks with the Lenders for some time and it has been agreed that there will be no Event of Default relating to any repayments that have been or may be missed up to 14 November 2022. DVRG is in the process of strengthening and reorganising the Board to reflect the recent fast pace of growth and that expected in 2023 and beyond.

Invinity Energy Systems (IES), a manufacturer of utility-grade energy storage, announced the sale of a 0.8 MWh Invinity VS3 flow battery system to Equans Belux for use at one of their sites in Belgium. The company said Invinity’s first VS3 sale into the European market is exciting, especially given the strength of the customer.

ANGLE (AGL), a liquid biopsy company, announced it has signed a distribution agreement with Promedeus s.r.o to enable and support the roll out of the FDA cleared and CE marked Parsortix® PC1 system across the Czech Republic for its intended use in metastatic breast cancer.

i3 Energy (I3E), an independent oil and gas company, said it has been notified that yesterday John Festival, Chairperson, purchased 1,000,000 ordinary shares of 0.01 pence each in the Company, at a price of CAD 0.355 per share and that Majid Shafiq, CEO, purchased 206,607 Ordinary Shares at a price of 24.2 pence per share.

San Leon (SLE), the independent oil and gas company focussed on Nigeria, said it was informed on 11 October 2022 that funds managed by Toscafund Asset Management LLP held 332,941,410 ordinary shares in the Company, representing 74.00% of the issued share capital of the Company.

BiON (BION) announced its final results for the sixteen-month period ended 30 April 2022. The company said that with effect from 7.30am on 1 July 2022, trading in its shares was suspended due to the company being unable to complete and publish the annual report within its financial reporting deadline of 30 June 2022. Given the annual report is now published, trading in the company’s shares will resume as from 7.30am today, 12 October 2022.

Kistos (KIST) announced that the reduction of capital required to effect the cancellation of the bonus shares issued on 6.00 p.m. on 10 October 2022; and the credit of €50,000,000 to the share premium account of the Company was approved yesterday by the High Court of Justice of England and Wales.

Sareum Holdings (SAR), a clinical stage biotechnology company, announced that it has been informed by Sierra Oncology, Inc. (a subsidiary of GSK plc that it intends to return the rights for SRA737 to the CRT Pioneer Fund LP. Sareum said it will discuss actively with CPF the potential options for future development opportunities for SRA737 and evaluate its next steps accordingly.

Castillo Copper (CCZ), a base metal explorer, announced that four drill-holes for a total of 488m have been completed at the Tors Tank Prospect, within the BHA Project’s East Zone, with encouraging initial observations and interpretations. The company said that subject to confirmation from final assay results, the geology team believe there is potential for cobalt and REE mineralisation.

Hostelworld (HSW) provided an update on trading up to 30 September 2022. The company said that since reporting results for the first half, it has seen significant improvements in its key financial metrics and performance indicators. The outlook for 2023 is encouraging and it expects its growth strategy to continue to deliver further significant benefits in FY 2023 and beyond.

Angus Energy (ANGS), announced that, following a scheduled maintenance shutdown last week, hourly throughput rates through the process plant (i.e. sales gas) now exceeds our October target production rate of 6 million standard cubic feet per day with well pressures holding in the high forties. Condensate production has stabilised at or around 120 barrels per day.

Evgen Pharma (EVG), a clinical stage drug development company, announced the start of recruitment for the pharmacokinetic/pharmacodynamic trial in healthy volunteers and the decision to commence an Investigator Sponsored clinical study for the glioblastoma programme.

East Star Resources (EST), the Kazakhstan-focused gold, rare earths and copper explorer, announced that all necessary approvals to commence fieldwork at the Talairyk heavy rare earths project in the Kostanay region of Kazakhstan have been received and drilling will commence imminently – several months ahead of schedule.

Dukemount Capital (DKE) said it has issued 74,575,000 ordinary shares to settle a 9.5% extension fee of £74,575 to its existing Noteholders. When issued, the New Shares will be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares in the share capital of the Company.

Author @ZaksTradersCafe

Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Linking Shareholders and Executives :Share Talk

If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates. Terms of Website Use All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned

Weekly Newsletter

Sign up to receive exclusive stock market content in your inbox, once a week.

We don’t spam! Read our privacy policy for more info.